They don’t have any deal with BP lined up and never will. You can take that to the bank!
If BP was truly interested they would have already invested a while back. These BP execs all ran as fast and far away as possible from NWBO after May 2022. They were all invited to NYAS TLD presentation in May 2022. The stock was already trading at close to $2B market cap in early May 2022. It would have been easier to justify a premium to purchase or license assets at that time.
LP is really desperate and that’s why she had to fold Advent into NWBO on the orders from the next set of financiers. That’s the only way LP’s financiers can continue to dump shares to bag holders next year with the carrot that a big pharma partnership is coming. In reality, it never will. We saw the same narrative just before they authorized C shares couple of years ago! ;)
In essence, you will see either an increase in authorized share count or reverse in the next month or two. The minions will spin this as a positive suggesting that the increase was done to allow big pharma to purchase a percentage stake in NWBO in lieu of L franchise for GBM or future co-development or something along those lines. On the other hand, if they end up doing a reverse split, then the NYSE or other major exchange up-listing stories will be floated.
Either way, it will lead to another 90% downside over the coming months.
Market Data 
Markets 
